Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
Dec 10
Love0

Botulinum Neurotoxin Type A as an Adjuvant to Reduce Scarring After Dermatological Surgery

By No Comments
INTRODUCTIONBotulinum neurotoxin type A (BoNTA) is widely used in the treatment of various conditions including focal spasticity and other neurological disorders, chronic migraine, and bladder problems.1–4 BoNTA formulations are also…
Read More
Dec 10
Love0

Seeing the Treatment of Psoriasis in a New Light: A Novel Medical Device Utilizing Localized Coal Tar and Narrowband UVB for Targeted Treatment of Plaque Psoriasis

By No Comments
INTRODUCTIONPsoriasis is a chronic, immune mediated skin disease that affects 2–4% of the world population.1 Phototherapy has been a mainstay treatment for psoriasis given its high efficacy, potential to induce…
Read More
Dec 10
Love0

A Multi-Centered Case-Control Study of Vitiligo Support Groups and Quality of Life

By No Comments
INTRODUCTIONVitiligo is an acquired chronic autoimmune cutaneous pigmentary disease of the skin, affecting nearly 1-2% of the population worldwide.1 The disease causes destruction of melanocytes and is characterized by depigmented…
Read More
Dec 10
Love0

Acne Vulgaris: The Majority of Patients Do Not Achieve Success According to FDA Guidance

By No Comments
INTRODUCTIONAcne vulgaris is a common inflammatory skin condition that affects approximately 85% of teenagers at some point in their lives and up to 20% may develop facial scarring.1,2 Although acne…
Read More
Dec 10
Love0

Analysis of Reddit Reveals Atopic Dermatitis Patient Questions

By No Comments
INTRODUCTIONAtopic dermatitis (AD) is a chronic relapsing inflammatory skin condition characterized by acute flare-ups of widespread rashes and pruritic lesions.1 Since the 1970s, the incidence of AD has increased 2-…
Read More
Dec 10
Love0

Efficacy of a Non-Comedogenic Hair Care Regimen for the Reduction of Mild-to-Moderate Truncal and Facial Acne: A Single-Arm 8-Week Study

By No Comments
INTRODUCTIONAcne is a common inflammatory skin condition, with a prevalence of ~85% in adolescence. Acne is not just a teenage condition, and the prevalence of acne in adult women has…
Read More
Dec 10
Love0

Revisiting the Skin Health and Beauty Pyramid: A Clinically Based Guide to Selecting Topical Skincare Products

By No Comments
INTRODUCTIONPyramids are highly stable structures with a broad base and pointed thinner top that have stood thousands of years in harsh environmental conditions. Therefore, it is appropriate that the pyramid…
Read More
Dec 10
Love0

Vitiligo Health Education: A Study of Accuracy and Engagement of Online Educational Materials

By No Comments
INTRODUCTIONVitiligo is a chronic autoimmune disorder affecting an estimated 0.5–2% of the worldwide population.1 It is characterized by the loss of pigmentation of the skin and overlying hair due to…
Read More
Dec 10
Love0

Concerns, Expectations, and Management Gaps Relating to Acne and Associated Scarring Identified from Survey Data

By No Comments
INTRODUCTIONAcne is a highly prevalent chronic disease, but its causes and effective treatments are often poorly understood by the public, even those who have acne themselves. Information can dispel misconceptions…
Read More
Dec 10
Love0

The Hypocrisy of Many Pharmacy Benefit Managers: “Pay No Attention to That Man Behind the Curtain”

By No Comments
Times have certainly changed with regard to gaining access to medications for our patients with acne and rosacea. I remember when you would give the patient a prescription and they…
Read More
Dec 10
Love0

Applications of Gold and Silver Nanoparticles in the Treatment of Acne Vulgaris: A Systematic Review

By No Comments
INTRODUCTIONAcne vulgaris is a common and chronic inflammatory disorder of the pilosebaceous unit affecting a majority of adolescents and possibly continuing into adulthood.1 The multifactorial pathophysiology of acne includes the…
Read More
Dec 10
Love0

Tazarotene 0.045% Lotion for Moderate-to-Severe Acne Patients: Pooled Phase 3 Analysis by Age and Sex

By No Comments
INTRODUCTIONSex and age are known to have a potential impact on the clinical effectiveness and tolerability of topical retinoid therapies for acne. Males tend to exhibit less epidermal water loss,…
Read More
« Previous
NextPrevious »

Search page

Advertisement

Popular

  • A Randomized Controlled Trial Analyzing the Likeability, Usability, and In-Use Efficacy of Mineral Sunscreens Across Diverse Skin Tones July 3, 2026
  • A Novel Retinoid and Salicylic Acid Topical Treatment for Moderate-Severe Acne July 2, 2026
  • JDD Podcasts: Catch-up Now! July 1, 2026
  • Management of Nail Toxicities From Fibroblast Growth Factor Receptor Inhibitors June 30, 2026
  • JDD in the News: Distinguishing Malassezia Folliculitis from Acne Vulgaris June 29, 2026

Advertisement

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |     ADVERTISING POLICY  |    MANAGE PREFERENCES  |  YOUR PRIVACY CHOICES

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference LVD        PDE       

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search

  • x-twitter
  • facebook
  • linkedin
  • instagram